Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Prevalentie van antimicrobiële resistentiegenen in ‘Bacteroides’ spp. en ‘Prevotella’ spp.
nov 2019